PT - JOURNAL ARTICLE AU - Feehan, Amy K AU - Fort, Daniel AU - Garcia-Diaz, Julia AU - Price-Haywood, Eboni AU - Velasco, Cruz AU - Sapp, Eric AU - Pevey, Dawn AU - Seoane, Leonardo TI - Point prevalence of SARS-CoV-2 and infection fatality rate in Orleans and Jefferson Parish, Louisiana, May 9-15, 2020 AID - 10.1101/2020.06.23.20138321 DP - 2020 Jan 01 TA - medRxiv PG - 2020.06.23.20138321 4099 - http://medrxiv.org/content/early/2020/06/24/2020.06.23.20138321.short 4100 - http://medrxiv.org/content/early/2020/06/24/2020.06.23.20138321.full AB - Using a novel recruitment method to reduce selection bias with paired molecular and antibody testing for SARS-CoV-2 infection, we determined point prevalence in a racially diverse municipality. Infections were highly variable by ZIP and differed by race. Overall census-weighted prevalence was 7.8% and the calculated infection fatality rate was 1.63%.Competing Interest StatementA charitable donation was made by ReNOLA, a non-profit, to cover the cost of recruitment by Public Democracy, owned and operated by author Eric Sapp. No other authors have competing interests.Funding StatementReNOLA funded the recruitment effort by Public Democracy but was not involved in the study design, execution, or analysis. Ochsner Health funded the remainder of the study and all authors, except for Eric Sapp, are employed by Ochsner Health. Therefore, Ochsner Health was involved in the design, execution, analysis, and writing of this paper. The authors have not been paid to write this article beyond regular employment contracts.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Ochsner Health IRB approved this study and can be contacted at irb{at}ochsner.org or by phone at 504-842-3535.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDe-identified data is available upon reasonable request to the corresponding author.